West Pharmaceutical Services (WST) Non-Current Debt (2009 - 2026)
West Pharmaceutical Services (WST) posted Non-Current Debt of $202.9 million for Q2 2026, little changed sequentially from $202.8 million in Q1 2026, and little changed YoY from $202.6 million in Q2 2025.
West Pharmaceutical Services (WST) Non-Current Debt (2009 - 2026) Analysis & Trends
West Pharmaceutical Services has reported Non-Current Debt for 18 years, with the latest figure at $202.9 million in Q2 2026.
- Quarterly Non-Current Debt changed 0.15% year-over-year to $202.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $202.9 million (changed 0.15% YoY) and the FY2025 annual result came in at $202.8 million, changed 0.1% from the prior year.
- Non-Current Debt was little changed at $202.9 million in Q2 2026 per WST's latest filing, from $202.8 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $252.5 million in Q1 2022 and troughed at $202.6 million in Q3 2024.
- A 5-year average of $210.4 million and a median of $206.0 million in 2024 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2026: Non-Current Debt retreated 17.59% in 2022, then rose 0.15% in 2026.
- Over 5 years, Non-Current Debt stood at $208.9 million in 2022, then declined by 1.01% to $206.8 million in 2023, then slipped by 2.03% to $202.6 million in 2024, then climbed by 0.1% to $202.8 million in 2025, then increased by 0.05% to $202.9 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $202.9 million, $202.8 million, and $202.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.51 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 4.15 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 399.42 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 12.55 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 202.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.57 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.86 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 8.62 Bn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 202.90 Mn |
| Mar 31, 2026 | 202.80 Mn |
| Dec 31, 2025 | 202.80 Mn |
| Sep 30, 2025 | 202.70 Mn |
| Jun 30, 2025 | 202.60 Mn |
| Mar 31, 2025 | 202.60 Mn |
| Dec 31, 2024 | 202.60 Mn |
| Sep 30, 2024 | 202.60 Mn |
| Jun 30, 2024 | 205.80 Mn |
| Mar 31, 2024 | 206.20 Mn |
| Dec 31, 2023 | 206.80 Mn |
| Sep 30, 2023 | 207.30 Mn |
| Jun 30, 2023 | 207.80 Mn |
| Mar 31, 2023 | 208.30 Mn |
| Dec 31, 2022 | 208.90 Mn |
| Sep 30, 2022 | 209.40 Mn |
| Jun 30, 2022 | 252.00 Mn |
| Mar 31, 2022 | 252.50 Mn |
| Dec 31, 2021 | 253.00 Mn |
| Sep 30, 2021 | 254.10 Mn |